Published DateClear

Start Date

End Date

Category

• Pipeline1
• Research1

Organizations

• Luxa Biotechnology1

Tags

• Retina512
• Clinical Trials450
• Products441
• Research410
• Technology326
• FDA303
• AMD264
• Glaucoma238
• Eye Drops224
• Dry Eye191

• Tags: stem cell therapy✕

Clear all

Pipeline

Luxa Biotechnology releases FIH data on RPE cell therapy for dry AMD

Stem cell-based replacement therapy shows potential with substantial BCVA gains in worse-seeing and reversal of disease trajectory in better-seeing patients.

Research

Stem cell therapy trial for cornea regeneration reports promising short-term data

All patients undergoing CALEC experienced restored cornea surfaces after 12 months.